Search - tctmd.com

Displaying 941 - 960 of 1159

Sort: Relevancy | Date

News Industry News

New Study Evaluates “Triple Therapy” Regimens After Drug-Eluting Stenting in Patients Requiring Oral Anticoagulation

September 15, 2014

News Conference News TCT 2014

New Devices May Help Overcome the Issue of Paravalvular Regurgitation After TAVR

September 15, 2014

News Conference News TCT 2014

PFO Closure for Stroke: A Call to Revise the Guidelines

September 14, 2014

Presentation TCT 2014

Lack of Preclinical Understanding Underlies the Negative Randomized Trial Results!

Presenter: Robert S. Schwartz

September 13, 2014

News Conference News ESC 2014

ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall

Todd Neale

September 08, 2014

News Daily News

With Some Caveats, SAFE-PCI Shows Positive Signs for Radial Access in Women

Yael L. Maxwell

September 02, 2014

News Conference News ESC 2014

FRANCE2: Registry Shows Positive Outcomes for TAVR in High-Risk Diabetic Patients

Yael L. Maxwell

September 02, 2014

News Conference News ESC 2014

SYMPLICITY HTN-3: Renal Denervation Still Safe, Not Effective at 1 Year

Todd Neale

September 01, 2014

News Conference News ESC 2014

NOMI: Nitric Oxide May Do Wonders for STEMI But Not When Mixed with Nitroglycerin

Caitlin E. Cox

September 01, 2014

News Conference News ESC 2014

Algorithm Helps Identify MI Within 1 Hour in Patients with Acute Chest Pain

Todd Neale

August 31, 2014

News Daily News

One-Time Platelet Testing Appears Insufficient to Guide Clopidogrel Therapy

July 24, 2014

News Industry News

First US Patients Undergo Full-Body MRI Scans with Distinctive BIOTRONIK DX System Technology

July 08, 2014

News Daily News

PCI Efficacy Unaffected by HIV Status

Yael L. Maxwell

July 07, 2014

News Industry News

CardioDx Announces Aetna and Coventry Health Coverage for Corus® CAD Gene Expression Test

July 07, 2014

News Features

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

June 24, 2014

News Features

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

June 18, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

News Industry News

Novartis provides update on EU marketing authorization application for RLX030 in acute heart failure

May 23, 2014

News Conference News EuroPCR 2014

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Yael L. Maxwell

May 22, 2014

News Industry News

FDA Approves Expansion of BIOTRONIK ProMRI® ICD Trial to Include Full-Body Scans and DX Technology

May 22, 2014

Advertisement

New Study Evaluates “Triple Therapy” Regimens After Drug-Eluting Stenting in Patients Requiring Oral Anticoagulation

New Devices May Help Overcome the Issue of Paravalvular Regurgitation After TAVR

PFO Closure for Stroke: A Call to Revise the Guidelines

Lack of Preclinical Understanding Underlies the Negative Randomized Trial Results!

ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall

With Some Caveats, SAFE-PCI Shows Positive Signs for Radial Access in Women

FRANCE2: Registry Shows Positive Outcomes for TAVR in High-Risk Diabetic Patients

SYMPLICITY HTN-3: Renal Denervation Still Safe, Not Effective at 1 Year

NOMI: Nitric Oxide May Do Wonders for STEMI But Not When Mixed with Nitroglycerin

Algorithm Helps Identify MI Within 1 Hour in Patients with Acute Chest Pain

One-Time Platelet Testing Appears Insufficient to Guide Clopidogrel Therapy

First US Patients Undergo Full-Body MRI Scans with Distinctive BIOTRONIK DX System Technology

PCI Efficacy Unaffected by HIV Status

CardioDx Announces Aetna and Coventry Health Coverage for Corus® CAD Gene Expression Test

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Novartis provides update on EU marketing authorization application for RLX030 in acute heart failure

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

FDA Approves Expansion of BIOTRONIK ProMRI® ICD Trial to Include Full-Body Scans and DX Technology

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content